Results 311 to 320 of about 100,641 (375)

Comparing Parkinson's Disease Medications Categorised by Location in New South Wales, Australia: Linking the 45 and Up Study and the Pharmaceutical Benefits Scheme (PBS) Data. [PDF]

Aust J Rural Health
Logan PA, Micalos PS, Fealy S, Bramble M, Wong A.   +4 more
europepmc   +1 more source

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Treatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America. [PDF]

Front Pharmacol
Arias-Carrión O, Ortega-Robles E.
europepmc   +1 more source

The Effect of Deep Brain Stimulation on Sleep and Cognition in Patients With Parkinson's Disease

Journal of Sleep Research, EarlyView.
ABSTRACT Sleep–wake disturbances and cognitive decline are among the most common nonmotor symptoms of Parkinson's disease (PD). Deep brain stimulation (DBS) can successfully alleviate motor symptoms. However, the impact on sleep–wake disturbances and cognitive decline, and their interaction, is yet unclear.
Monique E. H. Valk‐Geuke, Gert J. Geurtsen, Rob M. A. de Bie, Rick Schuurman, Martijn Beudel, Esmée Verwijk   +5 more
wiley   +1 more source

Low-frequency activity in the subthalamic nucleus informs about the acute neuropsychiatric state in Parkinson's disease. [PDF]

NPJ Parkinsons Dis
Bernasconi E, Averna A, D'Onofrio V, Amstutz D, Herz DM, Alva L, Magalhães AD, Petermann K, Debove I, Lachenmayer ML, Nowacki A, Pollo C, Krack P, Sousa M, Tinkhauser G.   +14 more
europepmc   +1 more source

Vertebrobasilar dolichoectasia compresses midbrain, worsens Parkinson symptoms, and evokes Holmes tremor: A case report. [PDF]

Medicine (Baltimore)
Li J, Cheng N, Liu T, Rong Q.
europepmc   +1 more source

Can levodopa prevent cognitive decline in patients with Parkinson's disease?

, 2017
Masahiro Ikeda, Hiroshi Kataoka, Satoshi Ueno   +2 more
openalex   +1 more source

An In Vitro-In Vivo Comparison of Two Levodopa Dry Powder Products for Inhalation: A Randomized Trial Comparing Inbrija and Levodopa Cyclops. [PDF]

Pharmaceutics
Berends JME, Wimmenhove EJ, Hoppentocht M, Hagedoorn P, Frijlink HW, Grasmeijer F.   +5 more
europepmc   +1 more source

COMT inhibition with entacapone for patients with Parkinson's disease and motor complications: the novelty of continuous infusion. [PDF]

J Neural Transm (Vienna)
Jenner P, Nyholm D.
europepmc   +1 more source

Beta Power Response After Levodopa Intake in Parkinson's Disease Patients With Chronic Sensing-Enabled Deep Brain Stimulation. [PDF]

Ann Neurol
de Neeling MGJ, Keulen BJ, Stam MJ, Hubers D, de Bie RMA, van Wijk BCM, Schuurman PR, Buijink AWG, Beudel M.   +8 more
europepmc   +1 more source